Skip to main content
Figure 3 | BMC Medical Genomics

Figure 3

From: Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma

Figure 3

Promoter methylation and CpG content of decitabine-responsive genes in MCF-7 cell line. Of eighteen decitabine-induced genes from the MCF-7 breast cancer cell line, three are highly methylated, five have intermediate methylation levels, and ten have low levels of methylation. Highly methylated, decitabine-responsive genes have lower promoter CpG content. With increasing levels of methylation, CpG content of responsive genes increases. For extremely CpG-dense promoters, only those with low methylation levels are up-regulated. These observations are in accord with the melanoma data.

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us